Serial Number | 79274546 |
Word Mark | SIEN-NET |
Filing Date | Friday, November 8, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, January 19, 2021 |
Registration Number | 6248001 |
Registration Date | Tuesday, January 19, 2021 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 3, 2020 |
Goods and Services | Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of specific biological markers for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying specific biological markers for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying specific biological markers that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying specific biological markers that contain nucleic acid; antibodies that are specifically able to bind and capture specific biological markers for medical purposes; antibody fragments that are specifically able to bind and capture specific biological markers for medical purposes; antibody conjugates that are specifically able to bind and capture specific biological markers for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 23, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Sienna Cancer Diagnostics Ltd |
Party Type | 30 - Original Registrant |
Legal Entity Type | 83 - NOT AVAILABLE |
Address | AU |
Party Name | Sienna Cancer Diagnostics Ltd |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 83 - NOT AVAILABLE |
Address | AU |
Party Name | Sienna Cancer Diagnostics Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 83 - NOT AVAILABLE |
Address | AU |
Event Date | Event Description |
Sunday, May 16, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, April 23, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, April 23, 2021 | FINAL DISPOSITION PROCESSED |
Monday, April 19, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Friday, January 29, 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Tuesday, January 19, 2021 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, November 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 3, 2020 | PUBLISHED FOR OPPOSITION |
Monday, November 2, 2020 | NOTIFICATION PROCESSED BY IB |
Wednesday, October 14, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, October 14, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, October 14, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, September 24, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, September 10, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, September 9, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, September 9, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, March 27, 2020 | REFUSAL PROCESSED BY IB |
Monday, March 9, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, March 9, 2020 | REFUSAL PROCESSED BY MPU |
Wednesday, February 19, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, February 18, 2020 | NON-FINAL ACTION WRITTEN |
Wednesday, February 12, 2020 | ASSIGNED TO EXAMINER |
Friday, December 27, 2019 | APPLICATION FILING RECEIPT MAILED |
Monday, December 23, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, December 19, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |